Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of stock-based payment expenses

v3.22.1
Stockholders Equity (Details) - Schedule of stock-based payment expenses - Selling, General and Administrative Expenses [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Research and development expenses, net $ 258 $ 331
General and administrative 357 199
Total $ 615 $ 530